USANA Health Sciences, Inc.USNANYSE
Loading
EBITDA Over TimeContracting
Percentile Rank7
3Y CAGR-10.0%
5Y CAGR-13.9%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-10.0%/yr
vs -8.8%/yr prior
5Y CAGR
-13.9%/yr
Recent acceleration
Acceleration
-1.2pp
Decelerating
Percentile
P7
Near historical low
vs 5Y Ago
0.5x
Contraction
Streak
5 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$95.02M-3.9%
2024$98.86M-19.7%
2023$123.11M-5.5%
2022$130.22M-32.5%
2021$192.89M-4.0%
2020$200.96M+18.9%
2019$168.98M-10.3%
2018$188.35M+42.1%
2017$132.50M-12.9%
2016$152.10M-